Skip to content
Arctop logo — Decoding the language of the brain to empower the human expe...

Arctop

Decoding the language of the brain to empower the human experience.

Founded 2016 United States Los Angeles, United States 16 employees Series A Total: $15.00M Digital Health, Health Care +5

General Information

Company Name Arctop
Founded Year 2016
Location United States Los Angeles, United States
Employees 16
Industries Digital Health, Health Care, Health and Wellness +4
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Arctop. To contact Arctop, visit arctop.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Arctop compare?

A PDF of Arctop and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Arctop soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Arctop

Arctop is a cognition company that aims to revolutionize human life through widely-accessible technology. Founded in 2016, the company's mission is to decode the language of the brain and utilize artificial intelligence to interpret brain activity, including emotions, reactions, and intent. This groundbreaking approach enables Arctop to optimize skill training, innovate new forms of communication, and facilitate unprecedented adaptive experiences. Recently, Arctop received a significant $10.00M Series A investment on 10 October 2023. The notable investors involved in this funding round were Supermoon Capital and Fifth Growth Fund. The company is headquartered in the United States. With its transformative focus on decoding the brain and its signals, Arctop has the potential to disrupt multiple industries and significantly impact the future of technology and human experiences.

Business keywords: cognition technology, brain decoding, brain activity, human experience empowerment, skill training optimization, communication innovation, adaptive experiences, neuroscience, emotional analysis, intent interpretation, human life improvement, electric measurements, neurotechnology, startup

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $10.00M 2
Supermoon Capital, Fifth Growth Fund
10 Oct 2023
Seed Round $4.00M 1
Metropolis Ventures
01 Jul 2019
Pre Seed Round $1.00M 2
Script Capital, The MBA Fund
15 Jun 2017

Arctop Alternatives & Competitors

Arctop vs

An advanced VR/AR/XR and biometrics platform enabling precise guidance for optimized brain function...

Seed
23 employees
Health Care, VR/AR

FAQ About Arctop

Decoding the language of the brain to empower the human experience.
Arctop was founded in 2016.
Arctop is headquartered in Los Angeles, United States.
Arctop operates in Digital Health, Health Care, Health and Wellness, Productivity, Senior Care, VR/AR and Automotive. Its work centres on cognition technology, brain decoding, brain activity and human experience empowerment.
Arctop has approximately 16 employees.
Arctop has completed 3 funding rounds, raising a total of $15.00M. The latest funding stage is Series A.
Top alternatives and competitors to Arctop include Neo Auvra. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arctop and Neo Auvra are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Arctop, https://bouncewatch.com/company/arctop, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout